Topera
151,940 employees on LinkedIn · 2 known investors
Find your way into Topera
Sign up to find every way you can get introduced to Topera
- Your email: who you already know at Topera, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Topera team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Abbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
Investors · 2
Acquisitions · 1
Early investors' stakes continue via these dealsOptiMedica
OptiMedica develops ophthalmology equipment for cataract surgery, including phacoemulsification and laser-assisted cataract surgery systems along with intraocular lenses and implants. Its products serve eye surgeons performing cataract procedures.
Frequently asked questions
- What does Topera do?
- Abbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
- Who are Topera's investors?
- Topera's investors include New Enterprise Associates (NEA), OTV.
